Trump Strikes Drug-Pricing Deal With Pharma Giant Astrazeneca- MSNBC
ReutersOct 10, 2025 4:45 PM
Oct 10 (Reuters) -
TRUMP STRIKES DRUG-PRICING DEAL WITH PHARMA GIANT ASTRAZENECA- MSNBC
ASTRAZENECA, WHICH IS BASED IN THE U.K., HAS ALSO AGREED TO INVEST $50 BILLION IN ITS DRUG MANUFACTURING AND RESEARCH AND DEVELOPMENT IN THE US- MSNBC
Source https://tinyurl.com/hhmxf23y
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Investing in 5G & Telecom Infrastructure
Connectivity was always a progress stimulant. Telecommunication-enabled commerce, the telephone transformed communications, and the internet unleashed globalization. And now, the fifth-generation wireless technology, 5G, is next.TradingKey
9 hours ago
FOMC October Meeting Minutes: How Should Investors Respond?
In the context of the U.S. government shutdown and a period of limited economic data, the Federal Reserve’s release of its latest monetary policy meeting minutes and officials’ statements on 8 October will be particularly significant.TradingKey
Tue, Oct 7
U.S. Government Shutdown Commentary: Is a Stock Market Crash Imminent? Will Gold Prices Continue to Surge?
TradingKey - On 1 October 2025, the U.S. federal government officially entered a shutdown, impacting various asset classes. This article analyses two key markets most affected—U.S. equities and gold—to help investors identify potential opportunities.TradingKey
Wed, Oct 1
Broadcom Q3 FY2025 Earnings Review: AI Surge and VMware Synergy Fuel Record Performance
TradingKey - Broadcom Inc. (NASDAQ: AVGO) delivered a strong fiscal Q3 2025, with results driven by AI networking strength and continued VMware integration. Revenue and EPS both topped expectations, reinforcing the company’s role as an essential player in the AI infrastructure buildout.TradingKey
Fri, Sep 5
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.TradingKey
Mon, Jul 14
